V8
Alternative Names: V-8; V8 - ImmunitorLatest Information Update: 28 Jun 2024
At a glance
- Originator Immunitor Inc.
- Class Urologics; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Renal failure
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in Renal-failure in Canada (PO)
- 06 May 2020 Preclinical trials in Renal failure in Canada before May 2019 (Parenteral)
- 06 May 2020 Immunitor plans a phase II trial for Kidney failure (PO) in Mongolia in June 2020 (NCT04377243)